Detect and halt risky payments across the life sciences supply chain

Supply Chain

By SAS On Jul 19, 2024

Cut fraud, waste, error and abuse with a data-driven approach to payment integrity

It’s estimated that 4.57% of the total annual procurement spending in the private sector is lost to fraud and error. What would be the impact to life sciences organizations if you could stop that flow of cash out of the business? Even for smaller organizations, improving payment integrity could free up significant capital for strategic investments. In R&D, for example, it could free up funds for strategic acquisitions or returning cash to shareholders.

In this e-book, we’ll look at how a smarter, more data-driven approach to payment integrity helps life sciences companies gain faster and deeper visibility into their spending across R&D, manufacturing and distribution. A data-driven approach also helps highlight potential anomalies in real time for investigation by human experts.

First Name (required)

Last Name (required)

Email (required)

Phone/Mobile Number (required)

Designation (required)

Company Name (required)

Company Address (required)

City (required)

Postal Code (required)

I would like to be contacted by SAS representative.
Yes, I would like to receive email updates about SAS products, services and events.
For full details of how we will treat your information please view our privacy policy: SAS Privacy Policy

This is co-hosted by Express Pharma and SAS

By submitting this form, you are confirming you are an adult 18 years or older and agree to Express Pharma contacting you with marketing-related emails or by telephone. You may unsubscribe from receiving such communications from Express Pharma at any time. Express Pharma web sites and communications are subject to our Privacy Notice and Terms of Use.